ey0019.10-12 | Complications and comorbidities | ESPEYB19
P Loxton , K Narayan , CF Munns , ME Craig
ey0019.13-14 | Endocrinology | ESPEYB19
SA Amaratunga , TH Tayeb , P Dusatkova , S Pruhova , J Lebl
ey0019.15-11 | Assorted Conditions | ESPEYB19
J Verissimo , P Verhaeghen , N Goldman , M Weinstein , MT Ullman
ey0017.3-3 | Thyroid development | ESPEYB17
G Rurale , F Marelli , P Duminuco , L Persani
ey0017.5-2 | Advances in Clinical Practice | ESPEYB17
ME Robinson , P Trejo , T Palomo , FH Glorieux , F Rauch
ey0017.12-6 | Type 2 Diabetes | ESPEYB17
P Bjornstad , K Hughan , MM, et al. Kelsey
ey0016.1-3 | New Mechanisms | ESPEYB16
D Deveci , FA Martin , P Leopold , NM Romero
ey0016.11-7 | Tracking, Programming, and Epigenetics | ESPEYB16
S Lecoutre , P Petrus , M Ryden , C Breton
ey0016.13-2 | Diabetes | ESPEYB16
P Boulle , S Kehlenbrink , J Smith , D Beran , K Jobanputra
ey0016.15-17 | (1) | ESPEYB16
TJ Dening , P Joyce , M Kovalainen , H Gustafsson , CA Prestidge